Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2011

01-08-2011 | Review

The lung as a possible target for the immune reaction in myositis

Authors: Sonye K Danoff, Livia Casciola-Rosen

Published in: Arthritis Research & Therapy | Issue 4/2011

Login to get access

Abstract

Interstitial lung disease is a common manifestation of autoimmune myositis that confers significant morbidity and mortality. The vulnerability of the lung may offer insight into the etiology of this autoimmune disease. The frequency and patterns of lung injury vary based on the autoantibody. Antibodies against the aminoacyl-tRNA synthetases and melanoma differentiation-induced gene-5 are frequently associated with interstitial lung disease. Although the mechanisms underlying these associations have not been fully elucidated, emerging data highlight the importance of autoantigen expression and conformation in the target tissue (lung and muscle, in this case), as well as identifying relevant amplifying pathways (such as regeneration).
Appendix
Available only for authorised users
Literature
1.
go back to reference Frazier AR, Miller RD: Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest. 1974, 65: 403-407. 10.1378/chest.65.4.403.CrossRefPubMed Frazier AR, Miller RD: Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest. 1974, 65: 403-407. 10.1378/chest.65.4.403.CrossRefPubMed
2.
go back to reference Labirua A, Lundberg IE: Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010, 22: 633-638. 10.1097/BOR.0b013e32833f1970.CrossRefPubMed Labirua A, Lundberg IE: Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010, 22: 633-638. 10.1097/BOR.0b013e32833f1970.CrossRefPubMed
3.
go back to reference Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP: Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum. 2009, 60: 2183-2192. 10.1002/art.24631.PubMedCentralCrossRefPubMed Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP: Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum. 2009, 60: 2183-2192. 10.1002/art.24631.PubMedCentralCrossRefPubMed
4.
go back to reference Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB: Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest. 2009, 135: 1550-1556. 10.1378/chest.08-2233.CrossRefPubMed Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB: Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest. 2009, 135: 1550-1556. 10.1378/chest.08-2233.CrossRefPubMed
5.
go back to reference Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M, Camara B, Fournie B, Couret B, Hatron PY, Dubucquoi S, Hamidou M: Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford). 2010, 49: 972-976. 10.1093/rheumatology/kep455.CrossRef Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M, Camara B, Fournie B, Couret B, Hatron PY, Dubucquoi S, Hamidou M: Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford). 2010, 49: 972-976. 10.1093/rheumatology/kep455.CrossRef
6.
go back to reference Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ, Cordier JF, Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires: Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003, 22: 245-250. 10.1183/09031936.03.00026703.CrossRefPubMed Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ, Cordier JF, Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires: Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003, 22: 245-250. 10.1183/09031936.03.00026703.CrossRefPubMed
7.
go back to reference Crowson AN, Magro CM, Dawood MR: A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol. 2000, 27: 505-515. 10.1034/j.1600-0560.2000.027010505.x.CrossRefPubMed Crowson AN, Magro CM, Dawood MR: A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol. 2000, 27: 505-515. 10.1034/j.1600-0560.2000.027010505.x.CrossRefPubMed
8.
go back to reference Kasifoglu T, Korkmaz C, Ozkan R: Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis. Clin Rheumatol. 2006, 25: 731-733. 10.1007/s10067-005-0062-8.CrossRefPubMed Kasifoglu T, Korkmaz C, Ozkan R: Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis. Clin Rheumatol. 2006, 25: 731-733. 10.1007/s10067-005-0062-8.CrossRefPubMed
9.
go back to reference Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW: Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum. 1995, 38: 437-439. 10.1002/art.1780380324.CrossRefPubMed Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW: Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum. 1995, 38: 437-439. 10.1002/art.1780380324.CrossRefPubMed
10.
go back to reference Sato S, Kuwana M: Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010, 22: 639-643. 10.1097/BOR.0b013e32833f1987.CrossRefPubMed Sato S, Kuwana M: Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010, 22: 639-643. 10.1097/BOR.0b013e32833f1987.CrossRefPubMed
11.
go back to reference Nishikai M, Reichlin M: Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980, 23: 881-888. 10.1002/art.1780230802.CrossRefPubMed Nishikai M, Reichlin M: Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980, 23: 881-888. 10.1002/art.1780230802.CrossRefPubMed
12.
go back to reference Bunn CC, Bernstein RM, Mathews MB: Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med. 1986, 163: 1281-1291. 10.1084/jem.163.5.1281.CrossRefPubMed Bunn CC, Bernstein RM, Mathews MB: Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med. 1986, 163: 1281-1291. 10.1084/jem.163.5.1281.CrossRefPubMed
13.
go back to reference Mathews MB, Reichlin M, Hughes GR, Bernstein RM: Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med. 1984, 160: 420-434. 10.1084/jem.160.2.420.CrossRefPubMed Mathews MB, Reichlin M, Hughes GR, Bernstein RM: Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med. 1984, 160: 420-434. 10.1084/jem.160.2.420.CrossRefPubMed
14.
go back to reference Targoff IN: Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 1990, 144: 1737-1743.PubMed Targoff IN: Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 1990, 144: 1737-1743.PubMed
15.
go back to reference Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, Akizuki M, Targoff IN: Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999, 162: 2315-2320.PubMed Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, Akizuki M, Targoff IN: Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999, 162: 2315-2320.PubMed
16.
go back to reference Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N: Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007, 46: 1005-1008. 10.1093/rheumatology/kem045.CrossRef Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N: Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007, 46: 1005-1008. 10.1093/rheumatology/kem045.CrossRef
17.
go back to reference Hashish L, Trieu EP, Sadanandan P, Targoff IN: Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome [abstract]. Arthritis Rheum. 2005, 52: S312-10.1002/art.20784.CrossRef Hashish L, Trieu EP, Sadanandan P, Targoff IN: Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome [abstract]. Arthritis Rheum. 2005, 52: S312-10.1002/art.20784.CrossRef
18.
go back to reference Hengstman GJ, van Engelen BG, Vree Egberts WT, van Venrooij WJ: Myositis-specific autoantibodies: overview and recent developments. Curr Opin Rheumatol. 2001, 13: 476-482. 10.1097/00002281-200111000-00004.CrossRefPubMed Hengstman GJ, van Engelen BG, Vree Egberts WT, van Venrooij WJ: Myositis-specific autoantibodies: overview and recent developments. Curr Opin Rheumatol. 2001, 13: 476-482. 10.1097/00002281-200111000-00004.CrossRefPubMed
19.
go back to reference Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ: Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990, 77: 1019-1038.CrossRefPubMed Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ: Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990, 77: 1019-1038.CrossRefPubMed
20.
go back to reference Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T: Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity. 2006, 39: 233-241. 10.1080/08916930600622884.CrossRefPubMed Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T: Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity. 2006, 39: 233-241. 10.1080/08916930600622884.CrossRefPubMed
21.
go back to reference Katsumata Y, Ridgway WM, Oriss T, Gu X, Chin D, Wu Y, Fertig N, Oury T, Vandersteen D, Clemens P, Camacho CJ, Weinberg A, Ascherman DP: Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun. 2007, 29: 174-186. 10.1016/j.jaut.2007.07.005.PubMedCentralCrossRefPubMed Katsumata Y, Ridgway WM, Oriss T, Gu X, Chin D, Wu Y, Fertig N, Oury T, Vandersteen D, Clemens P, Camacho CJ, Weinberg A, Ascherman DP: Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun. 2007, 29: 174-186. 10.1016/j.jaut.2007.07.005.PubMedCentralCrossRefPubMed
22.
go back to reference Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP: Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007, 56: 3125-3131. 10.1002/art.22865.CrossRefPubMed Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP: Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007, 56: 3125-3131. 10.1002/art.22865.CrossRefPubMed
23.
go back to reference Gunawardena H, Betteridge ZE, McHugh NJ: Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol. 2008, 20: 675-680. 10.1097/BOR.0b013e328313bff4.CrossRefPubMed Gunawardena H, Betteridge ZE, McHugh NJ: Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol. 2008, 20: 675-680. 10.1097/BOR.0b013e328313bff4.CrossRefPubMed
24.
go back to reference Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y: Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005, 52: 1571-1576. 10.1002/art.21023.CrossRefPubMed Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y: Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005, 52: 1571-1576. 10.1002/art.21023.CrossRefPubMed
25.
go back to reference Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M: RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009, 60: 2193-2200. 10.1002/art.24621.CrossRefPubMed Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M: RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009, 60: 2193-2200. 10.1002/art.24621.CrossRefPubMed
26.
go back to reference Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006, 441: 101-105. 10.1038/nature04734.CrossRefPubMed Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006, 441: 101-105. 10.1038/nature04734.CrossRefPubMed
27.
go back to reference Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, Kawabata D, Ohmura K, Usui T, Fujii T, Okawa K, Mimori T: The RIG-I-like receptor IFIH1/ MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 2010, 49: 433-440. 10.1093/rheumatology/kep375.CrossRef Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, Kawabata D, Ohmura K, Usui T, Fujii T, Okawa K, Mimori T: The RIG-I-like receptor IFIH1/ MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 2010, 49: 433-440. 10.1093/rheumatology/kep375.CrossRef
28.
go back to reference Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, Masuda I, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H: Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010, 49: 1713-1719. 10.1093/rheumatology/keq149.CrossRef Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, Masuda I, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H: Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010, 49: 1713-1719. 10.1093/rheumatology/keq149.CrossRef
29.
go back to reference Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L: The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011, 65: 25-34. 10.1016/j.jaad.2010.09.016.PubMedCentralCrossRefPubMed Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L: The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011, 65: 25-34. 10.1016/j.jaad.2010.09.016.PubMedCentralCrossRefPubMed
30.
go back to reference Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F: Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010, 162 (2): 337-344. 10.1111/j.1365-2133.2009.09484.x.CrossRefPubMed Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F: Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010, 162 (2): 337-344. 10.1111/j.1365-2133.2009.09484.x.CrossRefPubMed
31.
go back to reference Lega JC, Cottin V, Fabien N, Thivolet-Bejui F, Cordier JF: Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?. J Rheumatol. 2010, 37: 1000-1009. 10.3899/jrheum.090652.CrossRefPubMed Lega JC, Cottin V, Fabien N, Thivolet-Bejui F, Cordier JF: Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?. J Rheumatol. 2010, 37: 1000-1009. 10.3899/jrheum.090652.CrossRefPubMed
32.
go back to reference Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med. 2005, 201: 591-601. 10.1084/jem.20041367.PubMedCentralCrossRefPubMed Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med. 2005, 201: 591-601. 10.1084/jem.20041367.PubMedCentralCrossRefPubMed
33.
go back to reference Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, Johnson MA, Wekerle H, Tschopp J, Jenne D, Hohlfeld R: Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest. 1996, 97: 2905-2910. 10.1172/JCI118749.PubMedCentralCrossRefPubMed Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, Johnson MA, Wekerle H, Tschopp J, Jenne D, Hohlfeld R: Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest. 1996, 97: 2905-2910. 10.1172/JCI118749.PubMedCentralCrossRefPubMed
34.
go back to reference Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999, 190: 815-826. 10.1084/jem.190.6.815.PubMedCentralCrossRefPubMed Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999, 190: 815-826. 10.1084/jem.190.6.815.PubMedCentralCrossRefPubMed
35.
go back to reference Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M, Rosen A, Casciola-Rosen LA: Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum. 2007, 56: 2729-2739. 10.1002/art.22790.CrossRefPubMed Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M, Rosen A, Casciola-Rosen LA: Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum. 2007, 56: 2729-2739. 10.1002/art.22790.CrossRefPubMed
36.
go back to reference Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciola-Rosen L, Hartlein M, Kron M, Yang D, Yiadom K, Dwivedi S, Plotz PH, Oppenheim JJ: Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med. 2002, 196: 781-791. 10.1084/jem.20020186.PubMedCentralCrossRefPubMed Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciola-Rosen L, Hartlein M, Kron M, Yang D, Yiadom K, Dwivedi S, Plotz PH, Oppenheim JJ: Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med. 2002, 196: 781-791. 10.1084/jem.20020186.PubMedCentralCrossRefPubMed
37.
go back to reference Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA: Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005, 57: 664-678. 10.1002/ana.20464.CrossRefPubMed Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA: Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005, 57: 664-678. 10.1002/ana.20464.CrossRefPubMed
38.
go back to reference Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, Nicod LP: Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J. 1997, 10: 2907-2912. 10.1183/09031936.97.10122907.CrossRefPubMed Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, Nicod LP: Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J. 1997, 10: 2907-2912. 10.1183/09031936.97.10122907.CrossRefPubMed
39.
go back to reference Yokoyama T, Sakamoto T, Shida N, Kinoshita M, Kunou Y, Karukaya R, Takamatsu M, Aizawa H: Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes. J Intensive Care Med. 2005, 20: 160-163. 10.1177/0885066605275391.CrossRefPubMed Yokoyama T, Sakamoto T, Shida N, Kinoshita M, Kunou Y, Karukaya R, Takamatsu M, Aizawa H: Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes. J Intensive Care Med. 2005, 20: 160-163. 10.1177/0885066605275391.CrossRefPubMed
40.
go back to reference Guglielmi S, Merz TM, Gugger M, Suter C, Nicod LP: Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J. 2008, 31: 213-217. 10.1183/09031936.00014707.CrossRefPubMed Guglielmi S, Merz TM, Gugger M, Suter C, Nicod LP: Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J. 2008, 31: 213-217. 10.1183/09031936.00014707.CrossRefPubMed
41.
go back to reference Takada K, Nagasaka K, Miyasaka N: Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity. 2005, 38: 383-392. 10.1080/08916930500124023.CrossRefPubMed Takada K, Nagasaka K, Miyasaka N: Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity. 2005, 38: 383-392. 10.1080/08916930500124023.CrossRefPubMed
Metadata
Title
The lung as a possible target for the immune reaction in myositis
Authors
Sonye K Danoff
Livia Casciola-Rosen
Publication date
01-08-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3347

Other articles of this Issue 4/2011

Arthritis Research & Therapy 4/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.